Indolocarbazole glycosides in inactive conformations

被引:10
作者
Facompré, M
Carrasco, C
Vezin, H
Chisholm, JD
Yoburn, JC
Van Vranken, DL
Bailly, C
机构
[1] INSERM, U524, F-59045 Lille, France
[2] IRCL, Lab Pharmacol Antitumorale, Ctr Oscar Lambret, F-59045 Lille, France
[3] USTL, Chim Organ Phys Lab, URA 351, CNRS, F-59655 Villeneuve Dascq, France
[4] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA
关键词
anticancer agents; DNA binding; molecular modeling; NMR spectroscopy; topoisomerase I;
D O I
10.1002/cbic.200200478
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Indolocarbazole glycosides related to rebeccamycin represent a promising category of antitumor agents targeting DNA and topoisomerase 1. These drugs prefer to adopt a closed conformation with an intramolecular hydrogen bond between the indole NH group and the pyranose oxygen atom. Three pairs of indolocarbazole monoglycosides bearing an NH or an N-methyl indole moiety were synthesized and their biological properties investigated at the molecular and cellular level. Replacing the indole NH proton with a methyl group reduces DNA interaction and abolishes activity against DNA topoisomerase 1. Surface plasmon resonance studies performed with a pair of water-soluble indolocarbazole glycosides and two hairpin oligonucleotides containing an [AT](4) or a [CG](4) sequence indicate that both the NH and the N-methyl derivative maintain a relatively high affinity for DNA (K-eq= 2-6 x 10(5) m(-1))but the incorporation of the methyl group restricts access to the DNA. The number of ligand binding sites (n) on the oligonucleotides is about twice as high for the NH compound compared to its N-methyl analogue. Modeling and H-1 NMR Studies demonstrate, that.. addition of the N-methyl group drives a radical change In conformation in which the orientation of the aglycone relative to the beta-glucoside is reversed. The loss of the closed conformation by the N-methyl derivatives perturbs thir ability to access DNA binding sites and prevents the drug from inhibiting topoisomerase I. As a consequence, the NH compounds exhibit potent cytotoxicity against CEM leukemia cells with an IC50 value in the 1 mum range, whereas the N-methyl analogues are 10 to 100 times less cytotoxic. These studies offer circumstantial evidence supporting the importance of the closed conformation in the interaction of bazole glycosides with their molecular targets, DNA and topoisomerase I.
引用
收藏
页码:386 / 395
页数:10
相关论文
共 25 条
[1]   Practical synthesis of a potent indolocarbazole-based, DNA topoisomerase inhibitor [J].
Akao, A ;
Hiraga, S ;
Iida, T ;
Kamatani, A ;
Kawasaki, M ;
Mase, T ;
Nemoto, T ;
Satake, N ;
Weissman, SA ;
Tschaen, DM ;
Rossen, K ;
Petrillo, D ;
Reamer, RA ;
Volante, RP .
TETRAHEDRON, 2001, 57 (43) :8917-8923
[2]  
Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43
[3]   Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group [J].
Anizon, F ;
Belin, L ;
Moreau, P ;
Sancelme, M ;
Voldoire, A ;
Prudhomme, M ;
Ollier, M ;
Severe, D ;
Riou, JF ;
Bailly, C ;
Fabbro, D ;
Meyer, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3456-3465
[4]  
Bailly C, 2001, METHOD ENZYMOL, V340, P610
[5]  
Bailly C, 1999, CANCER RES, V59, P2853
[6]   DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin [J].
Bailly, C ;
Riou, JF ;
Colson, P ;
Houssier, C ;
RodriguesPereira, E ;
Prudhomme, M .
BIOCHEMISTRY, 1997, 36 (13) :3917-3929
[7]   Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition [J].
Bailly, C ;
Qu, XG ;
Graves, DE ;
Prudhomme, M ;
Chaires, JB .
CHEMISTRY & BIOLOGY, 1999, 6 (05) :277-286
[8]  
BAILLY C, 2003, SMALL MOL DNA RNA BI, V2, P538
[9]  
BAKHMEDOVA AA, 1997, RUSS J BIOORG CHEM+, V23, P608
[10]  
Carrasco C, 2001, ANTI-CANCER DRUG DES, V16, P99